Cargando…

Antipsychotics-induced hyperprolactinemia and screening for macroprolactin

INTRODUCTION: High prolactin (PRL) concentrations are found in laboratory test results of patients on majority of antipsychotic drugs. Prevalence rates and degrees of severity of hyperprolactinemia (HPRL) based on PRL concentration may depend on the presence of macroprolactin in the serum. The aim o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ruljancic, Nedjeljka, Bakliza, Ana, Vuk Pisk, Sandra, Geres, Natko, Matic, Katarina, Ivezic, Ena, Grosic, Vladimir, Filipcic, Igor
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Croatian Society of Medical Biochemistry and Laboratory Medicine 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7745162/ https://www.ncbi.nlm.nih.gov/pubmed/33380894 http://dx.doi.org/10.11613/BM.2021.010707

Ejemplares similares

comparisation of ABO blood groups between female patiens diagnosed with depressive disorders an bipolar affective disorders
por: Vuk Pisk, S., et al.
Publicado: (2022)

The Clinical Significance and Utility of Routine Screening for Macroprolactin in Patients With Hyperprolactinemia
por: Zeng, Wanling, et al.
Publicado: (2021)

Bipolar disorder type II - will the new classification help in setting an adequate diagnosis
por: Vuk Pisk, S., et al.
Publicado: (2023)

Macroprolactin; A Frequent Cause of Misdiagnosed Hyperprolactinemia in Clinical Practice
por: Vaishya, Richa, et al.
Publicado: (2010)

SAT-456 Heterogeneity of Macroprolactin in Samples Suspected of False Hyperprolactinemia
por: Nguyen, Khanh Quynh, et al.
Publicado: (2019)

“Lactose free” depression- Antidepressant with and without lactose registered in Croatia
por: Svetinović, D., et al.
Publicado: (2023)

Hidden face of pandemic – Case study of an art therapy process during the pandemic of the virus COVID-19
por: Barun, I., et al.
Publicado: (2023)

Management of antipsychotic-induced hyperprolactinemia
por: Tewksbury, Ashley, et al.
Publicado: (2016)

Hyperprolactinemia with Antipsychotic Drugs in Children and Adolescents
por: Rosenbloom, Arlan L.
Publicado: (2010)

RTMS AND H7-COIL IN THE TREATMENT OF TINNITUS; MODIFIED PROTOCOL PRELIMINARY RESULTS
por: Geres, N., et al.
Publicado: (2023)

Optimizing laboratory defined macroprolactin algorithm
por: Šostarić, Milica, et al.
Publicado: (2019)

Correction: Hyperprolactinemia with antipsychotic drugs in children and adolescents
por: Rosenbloom, Arlan L
Publicado: (2013)

Hyperprolactinemia with antipsychotics and the need for magnetic resonance imaging
por: Molina Liétor, M.D.C., et al.
Publicado: (2022)

Hormonal alterations due to antipsychotic-related hyperprolactinemia
por: Montejo, A.L., et al.
Publicado: (2022)

Macroprolactin Molecular Heterogeneity and Variable Immunoassay Reactivity
por: Hashim, Ibrahim A, et al.
Publicado: (2021)

Reversal of symptomatic antipsychotic-induced hyperprolactinemia with addition of aripiprazole
por: Kotorki, Paraskevi, et al.
Publicado: (2010)

Association of ANKK1 polymorphism with antipsychotic‐induced hyperprolactinemia
por: Fedorenko, Olga Yu., et al.
Publicado: (2020)

Serum macroprolactin levels in pregnancy and association with thyroid autoimmunity
por: Guclu, Metin, et al.
Publicado: (2015)

FRI314 Prolactinoma And Macroprolactin; A Diagnostic Dilemma
por: Farooqi, Aneeba, et al.
Publicado: (2023)

Hyperprolactinemia during antipsychotics treatment increases the level of coagulation markers
por: Ishioka, Masamichi, et al.
Publicado: (2015)

Add-on Aripiprazole for Atypical Antipsychotic-induced, Clinically Significant Hyperprolactinemia
por: Raveendranthan, Dhanya, et al.
Publicado: (2018)

The effect of atypical antipsychotics on brain N-acetylaspartate levels in antipsychotic-naïve first-episode patients with schizophrenia: a preliminary study
por: Grošić, Vladimir, et al.
Publicado: (2014)

Prevalence of posttraumatic stress disorder following acute coronary syndrome and clinical characteristics of patients referred to cardiac rehabilitation
por: Sopek Merkaš, Ivana, et al.
Publicado: (2023)

Ultrafiltration – an alternative method to polyethylene glycol precipitation for macroprolactin detection
por: Beda-Maluga, Karolina, et al.
Publicado: (2015)

Art therapy and psychosis – experiences from the University psychiatric hospital „Sveti Ivan“
por: Barun, I., et al.
Publicado: (2022)

The validation of macroprolactin analysis by polyethylene glycol precipitation using Fujirebio Lumipulse
por: Vermue, Febe C., et al.
Publicado: (2022)

A Comment on “Add-on Aripiprazole for Atypical Antipsychotic-induced, Clinically Significant Hyperprolactinemia”
por: Naguy, Ahmed
Publicado: (2018)

Development of a Guideline for Antipsychotic-induced Hyperprolactinemia in Korea Using the ADAPTE Process
por: Kim, Hye Ri, et al.
Publicado: (2023)

Hyperprolactinemia
por: Majumdar, Abha, et al.
Publicado: (2013)

PM403. Comparison between addition of and switching to aripiprazole for resolving antipsychotic-induced hyperprolactinemia
por: Lee, Jung Suk, et al.
Publicado: (2016)

Hyperprolactinemia in patients taking antipsychotics: the importance of a shared approach between psychiatry and endocrinology
por: Mousinho, M., et al.
Publicado: (2023)

Treatment of Diabetic Ketoacidosis Associated With Antipsychotic Medication: Literature Review
por: Vuk, Antonia, et al.
Publicado: (2017)

Adjunctive Aripiprazole Versus Placebo for Antipsychotic-Induced Hyperprolactinemia: Meta-Analysis of Randomized Controlled Trials
por: Li, Xianbin, et al.
Publicado: (2013)

Pharmacological treatment strategies for antipsychotic-induced hyperprolactinemia: a systematic review and network meta-analysis
por: Lu, Zhe, et al.
Publicado: (2022)

Peony-Glycyrrhiza Decoction for Antipsychotic-Related Hyperprolactinemia in Patients with Schizophrenia: A Randomized Controlled Trial
por: Wang, Zhongbao, et al.
Publicado: (2023)

Teratogenicity and hyperprolactinemia
por: Andrade, Chittaranjan
Publicado: (2009)

F97. CHRONIC PHYSICAL MULTIMORBIDITIES, GENDER DISPARITIES AND TREATMENT OUTCOME IN SCHIZOPHRENIA
por: Filipčić, Igor, et al.
Publicado: (2018)

Using aripiprazole to reduce antipsychotic-induced hyperprolactinemia: meta-analysis of currently available randomized controlled trials
por: MENG, Meiling, et al.
Publicado: (2015)

Hyperprolactinemia-inducing antipsychotics increase breast cancer risk by activating JAK-STAT5 in precancerous lesions
por: Johnston, A. N., et al.
Publicado: (2018)

Sexual function and depressive symptoms in young women with elevated macroprolactin content: a pilot study
por: Krysiak, Robert, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_q0guj6e4oqc9vlc4iedh9q7s98